In patients with psoriasis and rheumatoid, there is a decrease in B3GNT2 gene activity, linking B3GNT2 to various autoimmune disorders (Tsoi et al. 2012; Okada et al. 2012). This evidence concerns the gene B3GNT2 and psoriasis.